CLL Advocates NZ Newsletters
CLL Advocates December Newsletter
As you probably noted the interim report of the Pharmac Review Panel was released by Hon Andrew…
CLL Advocates November Newsletter
Neil was the driving force and inspiring leader behind CLL Advocates and gave an enormous amount of…
Request for Feedback – October Newsletter
Our monthly newsletter has now been going for a year and a half, and I’d like to hear back from you…
CLLANZ Newsletter September 2021 – Learn the latest international developments in CLL treatments
CLLANZ Newsletter September 2021
Newsletter #13: Submission to Panel Reviewing Pharmac
Our major activity over the past month has been engaging with the independent Panel set up by the…
CLL Advocates Newsletter Issue 12
Covid-19 and CLL prevention and treatment - an update.
CLL Advocates Newsletter Issue 11
Skin infection (cellulitis) and CLL - a cautionary tale
CLL Advocates Newsletter Issue 10
Welcome to issue 10 of the CLL Advocates newsletter.
CLL Advocates Newsletter Issue 9
Welcome to issue 8 of the CLL Advocates newsletter.
CLL Advocates Newsletter Issue 8
Welcome to issue 8 of the CLL Advocates newsletter.
CLL Advocates Newsletter Issue 7
Welcome to issue 7 of the CLL Advocates newsletter. This month's newsletter shares our latest…
CLL Advocates NZ Newsletter Issue 6
Welcome to issue 6 of the CLL Advocates newsletter. This month's newsletter shares our latest…
CLL Advocates NZ Newsletter Issue 5
Welcome to issue 3 of the CLL Advocates newsletter. This month's newsletter focuses on research and…
CLL Advocates NZ Newsletter Issue 4
Welcome to issue 3 of the CLL Advocates newsletter. This month's newsletter focuses on research and…
CLL Advocates NZ Newsletter Issue 3
Welcome to issue 3 of the CLL Advocates newsletter. This month's newsletter focuses on research and…
CLL Advocates NZ Newsletter Issue 2
Welcome to our first CLL Advocates newsletter. Like many organisations, we weren’t able to…
CLL Advocates NZ Newsletter Issue 1
Welcome to our first CLL Advocates newsletter. Like many organisations, we weren’t able to…